Nguyen
07-23-2019, 02:23 PM
"
The American Society of Clinical Oncology’s (ASCO) Targeted Agent and Profiling Utilization Registry (TAPUR) clinical study has added the enrollment of additional patient groups and continues to grow with more than 500 participants and 16 therapies now available. The purpose of TAPUR is to help cancer patients who have exhausted standard options access targeted study drugs matched to the genomic profiles of their cancers and provide physicians assistance in interpreting genomic results and identifying potential treatment options. (1)"
https://news.cancerconnect.com/breast-cancer/keytruda-promising-in-advanced-breast-cancer-with-high-tumor-mutational-burden-euV6bZI0iU-3m1JEn5mDyg/
The American Society of Clinical Oncology’s (ASCO) Targeted Agent and Profiling Utilization Registry (TAPUR) clinical study has added the enrollment of additional patient groups and continues to grow with more than 500 participants and 16 therapies now available. The purpose of TAPUR is to help cancer patients who have exhausted standard options access targeted study drugs matched to the genomic profiles of their cancers and provide physicians assistance in interpreting genomic results and identifying potential treatment options. (1)"
https://news.cancerconnect.com/breast-cancer/keytruda-promising-in-advanced-breast-cancer-with-high-tumor-mutational-burden-euV6bZI0iU-3m1JEn5mDyg/